Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
Company profile
Ticker
AXDX
Exchange
Website
CEO
John Phillips
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Perkinelmer • Bio-Rad Laboratories • Waters • Avantor • Illumina • Mettler-Toledo International • Bruker • Coherent • Seer ...
Former names
ACCELR8 TECHNOLOGY CORP
SEC CIK
Corporate docs
Subsidiaries
Accelerate Diagnostics UK Limited • Accelerate Diagnostics S.L. • Accelerate Diagnostics GmbH • Accelerate Diagnostics SARL • Accelerate Diagnostics B.V. • Accelerate Diagnostics Holdings, LLC ...
IRS number
841072256
AXDX stock data
News
Accelerate Diagnostics Earnings: A Preview
12 Aug 22
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
14 Jul 22
Accelerate Diagnostics Announces Commercialization In Europe Of Its Accelerate Arc System Having Completed IVDR Registration
11 Jul 22
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
1 Jul 22
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
28 Jun 22
Press releases
Accelerate Diagnostics scheduled call to review 2022 second quarter results
25 Jul 22
Accelerate Diagnostics announces commercialization in Europe of its Accelerate Arc™ system having completed IVDR registration
11 Jul 22
Thinking about buying stock in Neurosense Therapeutics, Boxed, Snap, RealReal, or Accelerate Diagnostics?
27 Jun 22
Thinking about buying stock in Li Auto, F-Star Therapeutics, Geovax Labs, Accelerate Diagnostics, or Funko?
23 Jun 22
Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022
23 May 22
Investment data
Securities sold
Number of investors
Calendar
16 May 22
13 Aug 22
31 Dec 22
Financial summary
| Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 13.65M | 13.65M | 13.65M | 13.65M | 13.65M | 13.65M |
| Cash burn (monthly) | 8.75M | 2.42M | 5.3M | 6.24M | 4.2M | 3.88M |
| Cash used (since last report) | 38.71M | 10.72M | 23.44M | 27.6M | 18.59M | 17.17M |
| Cash remaining | -25.05M | 2.93M | -9.79M | -13.95M | -4.94M | -3.51M |
| Runway (months of cash) | -2.9 | 1.2 | -1.8 | -2.2 | -1.2 | -0.9 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Jun 22 | Phillips Jack | Common Stock | Sell | Dispose S | No | No | 0.91 | 28,198 | 25.66K | 242,035 |
| 22 Jun 22 | Phillips Jack | Common Stock | Option exercise | Acquire M | No | No | 0 | 62,160 | 0 | 270,233 |
| 22 Jun 22 | Phillips Jack | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 62,160 | 0 | 62,160 |
| 31 May 22 | Francesconi Louise | RSU Common Stock | Grant | Acquire A | No | No | 0 | 75,949 | 0 | 75,949 |
Institutional ownership, Q1 2022
55.8% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 107 |
| Opened positions | 13 |
| Closed positions | 12 |
| Increased positions | 29 |
| Reduced positions | 33 |
| 13F shares | Current |
|---|---|
| Total value | 128.55M |
| Total shares | 38.89M |
| Total puts | 158.9K |
| Total calls | 12.3K |
| Total put/call ratio | 12.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Schuler Jack W | 18.28M | $90.69M |
| Oracle Investment Management | 2.73M | $3.93M |
| BLK Blackrock | 2.3M | $3.32M |
| Baird Financial | 1.74M | $2.51M |
| Griffin Asset Management | 1.5M | $2.16M |
| Vanguard | 1.32M | $1.9M |
| STT State Street | 1.23M | $1.78M |
| Cannell Peter B & Co | 1.09M | $1.57M |
| AXAHF Axa | 913.51K | $1.32M |
| Blair William & Co | 667.1K | $961K |
Financial report summary
?Competition
Thermo Fisher Scientific • Danaher • Luminex • Interpace Biosciences • Bruker • Opgen • GenMark Diagnostics • T2 BiosystemsContent analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
advance, albeit, Arc, ArcTM, attain, begun, beneficial, bifurcated, bond, build, commitment, committed, COVID, daily, detrimental, difficulty, driven, ease, employment, enable, enabling, environment, equitable, exceed, expenditure, favorable, fourth, front, half, hand, iii, incorporate, laser, layer, leaving, leveraging, lifted, lingering, location, margin, negotiated, obsolete, Omicron, point, premium, produce, proper, proven, quotient, refinanced, refinancing, reliable, retrospective, satisfaction, science, shortly, stipulated, strategy, successfully, superior, transition, troubled, trustee, unclear, view, vintage, work, working
Removed:
accreted, addressing, administered, affiliated, agree, allocate, annum, apply, approved, assigned, assignment, authorization, bad, Brown, Chief, Clarifying, complexity, cumulatively, cutting, deducting, demonstration, derivative, determination, disbursement, established, evidencing, examination, execution, expansion, external, fewer, Flexibility, forfeited, forgiven, herd, hierarchy, immunity, impacting, impeding, improved, Imputation, impute, informed, installed, interaction, IRS, John, Joint, judgmental, larger, lender, long, maintaining, Matthew, Miller, mortgage, netted, nonconvertible, November, obligor, originally, Patience, Paycheck, permitted, PPP, prescribed, President, promissory, qualify, reinvesting, released, Relief, rent, representing, SBA, scope, separately, separating, Simplifying, Small, Strobeck, study, submitted, taxable, unchanged, vaccination, week
Financial reports
Current reports
8-K
Other Events
30 Jun 22
8-K
Material Modifications to Rights of Security Holders
17 May 22
8-K
Accelerate Diagnostics Reports First Quarter 2022 Financial Results
16 May 22
8-K
Entry into a Material Definitive Agreement
25 Mar 22
8-K
Entry into a Material Definitive Agreement
21 Mar 22
8-K
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results
8 Mar 22
8-K
Departure of Directors or Certain Officers
3 Feb 22
8-K
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
13 Jan 22
8-K
Accelerate Diagnostics Reports Third Quarter 2021 Financial Results
12 Nov 21
8-K
Accelerate Diagnostics Reports Second Quarter 2021 Financial Results
12 Nov 21
Registration and prospectus
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 May 22
S-8
Registration of securities for employees
20 May 22
D
$4M in equity, sold $4M, 3 investors
7 Apr 22
S-3
Shelf registration
3 Feb 22
D
$30.45M in equity, sold $30.45M, 3 investors
28 Sep 21
Other
SD
Conflict minerals disclosure
27 May 22
EFFECT
Notice of effectiveness
14 Feb 22
CORRESP
Correspondence with SEC
8 Feb 22
UPLOAD
Letter from SEC
7 Feb 22
SD
Conflict minerals disclosure
28 May 21
EFFECT
Notice of effectiveness
5 Feb 21
CORRESP
Correspondence with SEC
31 Jan 21
UPLOAD
Letter from SEC
31 Jan 21
SD
Conflict minerals disclosure
5 Aug 20
SD
Conflict minerals disclosure
30 May 19
Ownership
4
Accelerate Diagnostics / JACK W SCHULER ownership change
10 Aug 22
3
Accelerate Diagnostics / Larry Michael Mertz ownership change
13 Jul 22
4
Accelerate Diagnostics / Jack Phillips ownership change
24 Jun 22
4
Accelerate Diagnostics / JACK W SCHULER ownership change
22 Jun 22
4
Accelerate Diagnostics / WAYNE BURRIS ownership change
2 Jun 22
4
Accelerate Diagnostics / Charles M Watts ownership change
2 Jun 22
4
Accelerate Diagnostics / BRINK FRANK JM TEN ownership change
2 Jun 22
4
Accelerate Diagnostics / Matthew Strobeck ownership change
2 Jun 22
4
Accelerate Diagnostics / JACK W SCHULER ownership change
2 Jun 22
4
Accelerate Diagnostics / JOHN PATIENCE ownership change
2 Jun 22
Patents
Utility
Instrument and System for Rapid Microorganism Identification and Antimicrobial Agent Susceptibility Testing
26 May 22
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.
Utility
Sensitive and Rapid Determination of Antimicrobial Susceptibility
31 Mar 22
The present invention relates to moving microorganisms to a surface, where they are grown in the presence and absence of antimicrobials, and by monitoring the growth of the microorganisms over time in the two conditions, their susceptibility to the antimicrobials can be determined.
Utility
Lens-free Holographic Optical System for High Sensitivity Label-free Microbial Growth Detection and Quantification for Screening, Identification, and Susceptibility Testing
3 Mar 22
Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample.
Utility
Lens-free Holographic Optical System for High Sensitivity Label-free Microbial Growth Detection and Quantification for Screening, Identification, and Susceptibility Testing
13 Jan 22
Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample.
Utility
Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
10 Aug 21
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.
Transcripts
2022 Q1
Earnings call transcript
17 May 22
2021 Q4
Earnings call transcript
9 Mar 22
2021 Q3
Earnings call transcript
10 Nov 21
2021 Q2
Earnings call transcript
8 Aug 21
2021 Q1
Earnings call transcript
7 May 21
2020 Q4
Earnings call transcript
24 Feb 21
2020 Q3
Earnings call transcript
7 Nov 20
2020 Q2
Earnings call transcript
8 Aug 20
2020 Q1
Earnings call transcript
9 May 20
2019 Q4
Earnings call transcript
27 Feb 20
Reddit threads
Daily Discussion Thread - August 12th, 2022
12 Aug 22
Daily Discussion Thread - May 16th, 2022
16 May 22
Daily Discussion Thread - May 13th, 2022
13 May 22
Daily Discussion Thread - March 8th, 2022
8 Mar 22
Daily Discussion Thread - March 7th, 2022
7 Mar 22
Daily Discussion Thread - February 28th, 2022
28 Feb 22
Daily Discussion Thread - February 22nd, 2022
22 Feb 22
Daily Discussion Thread - February 21st, 2022
21 Feb 22
Penny Stocks With Recent Insider Buying & Who Bought - $XSPA $VERO $AXDX $AMRX
20 Dec 21
Daily Discussion Thread - November 9th, 2021
9 Nov 21